Cargando…

Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide

Chronic kidney disease-mineral bone disorder is frequent in patients with renal failure. It is characterized by abnormalities in mineral and bone metabolism with resulting hyperphosphatemia, low serum vitamin D, secondary hyperparathyroidism, altered bone morphology and strength, higher risk of bone...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cernaro, Valeria, Santoro, Domenico, Lacquaniti, Antonio, Costantino, Giuseppe, Visconti, Luca, Buemi, Antoine, Buemi, Michele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749089/ https://www.ncbi.nlm.nih.gov/pubmed/26893577 http://dx.doi.org/10.2147/IJNRD.S78040

Ejemplares similares

Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease
por: Visconti, Luca, et al.
Publicado: (2016)

Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients
por: Floege, Jürgen, et al.
Publicado: (2015)

Xanthine Oxidase Inhibitors for Improving Renal Function in Chronic Kidney Disease Patients: An Updated Systematic Review and Meta-Analysis
por: Pisano, Anna, et al.
Publicado: (2017)

Beneficial effects of oral pure caffeine on oxidative stress
por: Metro, Daniela, et al.
Publicado: (2017)

Role of Vitamin D Status in Diabetic Patients with Renal Disease
por: Gembillo, Guido, et al.
Publicado: (2019)

Role of Paricalcitol in Modulating the Immune Response in Patients with Renal Disease
por: Lucisano, Silvia, et al.
Publicado: (2015)

Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis
por: Bolignano, Davide, et al.
Publicado: (2017)

Vascular access for hemodialysis: current perspectives
por: Santoro, Domenico, et al.
Publicado: (2014)

Management of dyslipidaemia in patients with chronic kidney disease: a position paper endorsed by the Italian Society of Nephrology
por: Pontremoli, Roberto, et al.
Publicado: (2020)

One-Year Historical Cohort Study of the Phosphate Binder Sucroferric Oxyhydroxide in Patients on Maintenance Hemodialysis
por: Kendrick, Jessica, et al.
Publicado: (2019)

Effect of the phosphate binder sucroferric oxyhydroxide in dialysis patients on endogenous calciprotein particles, inflammation, and vascular cells
por: Thiem, Ursula, et al.
Publicado: (2022)

Vitamin D Receptor Gene Polymorphism and Left Ventricular Hypertrophy in Chronic Kidney Disease
por: Santoro, Domenico, et al.
Publicado: (2014)

The effect of phosphate binder therapy with sucroferric oxyhydroxide on calcification propensity in chronic haemodialysis patients: a randomized, controlled, crossover trial
por: Thiem, Ursula, et al.
Publicado: (2020)

Phosphate binder pill burden, adherence, and serum phosphorus control among hemodialysis patients converting to sucroferric oxyhydroxide
por: Gray, Kathryn, et al.
Publicado: (2019)

Iron-based phosphate binders: do they offer advantages over currently available phosphate binders?
por: Negri, Armando Luis, et al.
Publicado: (2015)

Chronic Kidney Disease Requiring Healthcare Services: A New Approach to Evaluate Epidemiology of Renal Disease
por: Trifirò, Gianluca, et al.
Publicado: (2014)

Renal amyloidosis in cystic fibrosis: role of colchicine therapy
por: Santoro, Domenico, et al.
Publicado: (2014)

Both IL-1β and TNF-α Regulate NGAL Expression in Polymorphonuclear Granulocytes of Chronic Hemodialysis Patients
por: Arena, Adriana, et al.
Publicado: (2010)

Emerging markers of cachexia predict survival in cancer patients
por: Mondello, Patrizia, et al.
Publicado: (2014)

A comparison between the combined effect of calcium carbonate with sucroferric oxyhydroxide and other phosphate binders: an in vitro and in vivo experimental study
por: Yaguchi, Atsushi, et al.
Publicado: (2019)

Autoimmune Thyroiditis and Glomerulopathies
por: Santoro, Domenico, et al.
Publicado: (2017)

Phosphate binding by sucroferric oxyhydroxide ameliorates renal injury in the remnant kidney model
por: Nemoto, Yoshikazu, et al.
Publicado: (2019)

Sexual Dysfunction in Women with Diabetic Kidney
por: Satta, Ersilia, et al.
Publicado: (2014)

Socio-Economic Factors, Food Habits and Phosphorus Levels in Patients on Hemodialysis
por: Santoro, Domenico, et al.
Publicado: (2015)

Mitochondrial Disease (MELAS Syndrome) Discovered at the Start of Pregnancy in a Patient with Advanced CKD: A Clinical and Ethical Challenge
por: Santoro, Domenico, et al.
Publicado: (2019)

Interplay of Vitamin D, Erythropoiesis, and the Renin-Angiotensin System
por: Santoro, Domenico, et al.
Publicado: (2015)

Changes in serum albumin and other nutritional markers when using sucroferric oxyhydroxide as phosphate binder among hemodialysis patients: a historical cohort study
por: Kalantar-Zadeh, Kamyar, et al.
Publicado: (2019)

Competitive Carboxylate–Silicate Binding at Iron Oxyhydroxide Surfaces
por: Cheng, Wei, et al.
Publicado: (2021)

Prescribing pattern of medicines in chronic kidney disease with emphasis on phosphate binders
por: Bajait, Chaitali S, et al.
Publicado: (2014)

Safety and efficacy of sucroferric oxyhydroxide in pediatric patients with chronic kidney disease
por: Greenbaum, Larry A., et al.
Publicado: (2020)

Correlation between Hyperkalemia and the Duration of Several Hospitalizations in Patients with Chronic Kidney Disease
por: Calabrese, Vincenzo, et al.
Publicado: (2022)

Iron-related parameters in dialysis patients treated with sucroferric oxyhydroxide
por: Covic, Adrian C., et al.
Publicado: (2017)

Spectroelectrochemical study of water oxidation on nickel and iron oxyhydroxide electrocatalysts
por: Francàs, Laia, et al.
Publicado: (2019)

Phosphate Control in Peritoneal Dialysis Patients: Issues, Solutions, and Open Questions
por: Cernaro, Valeria, et al.
Publicado: (2023)

Constructing nickel–iron oxyhydroxides integrated with iron oxides by microorganism corrosion for oxygen evolution
por: Yang, Huan, et al.
Publicado: (2022)

Effects of Sucroferric Oxyhydroxide Compared to Lanthanum Carbonate and Sevelamer Carbonate on Phosphate Homeostasis and Vascular Calcifications in a Rat Model of Chronic Kidney Failure
por: Phan, Olivier, et al.
Publicado: (2015)

C3 glomerulopathy in cystic fibrosis: a case report
por: Santoro, Domenico, et al.
Publicado: (2018)

Simultaneous nephrectomy during kidney transplantation for polycystic kidney disease does not detrimentally impact comorbidity and graft survival
por: Darius, Tom, et al.
Publicado: (2022)

Medical record linkage in health information systems by approximate string matching and clustering
por: Sauleau, Erik A, et al.
Publicado: (2005)

Skin Involvement and Pulmonary Hypertension Are Associated with Vitamin D Insufficiency in Scleroderma
por: Atteritano, Marco, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3gqdvc7r2t1139nohe4h417llj